Inscobee Inc. - 01 Dec 2025 SCHEDULE 13D/A Report for Apimeds Pharmaceuticals US, Inc. Common Stock (APUS)

Filing Manager: Inscobee Inc.
Reporting Manager: Apimeds Inc.
Security: Apimeds Pharmaceuticals US, Inc. Common Stock
Symbol: APUS
Shares outstanding: 12,584,892 shares
Disclosed Ownership: 4,316,618 shares
Ownership: 34%
Form type: SCHEDULE 13D/A
Filing time: 26 Jan 2026, 06:03:26 UTC
Date of event: 01 Dec 2025
Previous filing: 19 May 2025
SEC: View on sec.gov

Reporting Managers (2)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
Inscobee Inc.	17%	2,099,747	2,099,747	0	/s/ You In Soo	You In Soo, Chief Executive Officer	0002057997
Apimeds Inc.	34%	4,316,618	4,316,618	0	/s/ You In Soo	You In Soo, Chief Executive Officer